Elucidata B2B Case Studies & Customer Successes

Elucidata is a pioneering life sciences MLOps company for the future that transforms biological discovery by integrating different forms of biomedical data. They support discovery programs at Pfizer, Bristol Myers Squibb, Genentech, Stanford and Yale and have 35+ research partners from premier biopharma companies and research labs. They are a 150+ multi-disciplinary team of experts based across the US, Canada, and India. In September 2022, they raised $16 million in their Series A round led by Eight Roads and F-Prime along with their old investors Hyperplane and IvyCap.

Case Studies

Showing 25 Elucidata Customer Success Stories

a biopharma company predicts spatially resolved gene expression faster and more cost-effectively with Elucidata

Biopharma Company

Cambridge-Based Oncology-Focused Company accelerates target identification by 75% with Elucidata

Cambridge-Based Oncology-Focused Company

a Cambridge-based RNAi therapeutics company achieves 2X faster gene identification with Elucidata's AI-ready single-cell data pipelines

Cambridge-based RNA Interference (RNAi) Therapeutics Company

Cell-Type Annotation Research Company accelerates scRNA-seq cell-type annotation with Elucidata's Polly

Cell-Type Annotation Research Company

Celsius achieves 4x faster insights with Elucidata's single-cell infrastructure

Celsius

a clinical-stage pharmaceutical company achieves 6X faster clinico-genomic data integration and analysis with Elucidata’s Polly

Clinical-stage Pharmaceutical Company

Curated Biomedical Company predicts liver cancer survivability with Elucidata’s Polly

Curated Biomedical Company

an early-stage US-based pharmaceutical company achieves ~80% faster gene target identification and validation with Elucidata

Early-stage US-based Pharmaceutical Company

a leading genomics-based drug discovery company achieves ~$3M cost reduction with Elucidata’s curated public data platform

Leading Genomics-based Drug Discovery Company

Leading Oncology Company speeds up drug screening with Elucidata’s Drug OmixAtlas

Leading Oncology Company

a leading pharmaceutical company achieves no-code, real-time biomedical data retrieval with Elucidata’s AI-powered Polly chatbot

Leading Pharmaceutical Company

Elucidata B2B Case Studies & Customer Successes

Case Studies

a biopharma company predicts spatially resolved gene expression faster and more cost-effectively with Elucidata

Cambridge-Based Oncology-Focused Company accelerates target identification by 75% with Elucidata

a Cambridge-based RNAi therapeutics company achieves 2X faster gene identification with Elucidata's AI-ready single-cell data pipelines

Cell-Type Annotation Research Company accelerates scRNA-seq cell-type annotation with Elucidata's Polly

Celsius achieves 4x faster insights with Elucidata's single-cell infrastructure

a clinical-stage pharmaceutical company achieves 6X faster clinico-genomic data integration and analysis with Elucidata’s Polly

Curated Biomedical Company predicts liver cancer survivability with Elucidata’s Polly

an early-stage US-based pharmaceutical company achieves ~80% faster gene target identification and validation with Elucidata

Global Biopharma Company slashes research costs by 70% with Elucidata's AI-powered data curation

Hookipa Pharmaceuticals achieves 7x faster translational research insights with Elucidata’s Polly

a leading diagnostics company accelerates biomarker discovery with Elucidata's Polly

a leading genomics-based drug discovery company achieves ~$3M cost reduction with Elucidata’s curated public data platform

Leading Oncology Company speeds up drug screening with Elucidata’s Drug OmixAtlas

a leading pharmaceutical company achieves no-code, real-time biomedical data retrieval with Elucidata’s AI-powered Polly chatbot

Leading RNAi Therapeutics Company achieves 4× faster, audit-ready RFP capacity modeling with Elucidata's Polly Xtract

a leading RNAi therapeutics company cuts Pre-IND reporting time 4X with Elucidata’s Polly Platform

a London-based therapeutics company accelerates proteomics research with Elucidata's Polly

Massachusetts-based therapeutics company accelerates AML target assessment with Elucidata’s Polly

National Center for Advancing Translational Sciences accelerates metabolomics analysis with Elucidata Polly

Polly achieves 3× faster spatial metabolomics data-to-insight with Elucidata's Polly platform

Polly achieves 5X lower-cost, high-throughput STAR RNA-seq data processing with Elucidata's Polly platform

Renowned Biopharmaceutical Company accelerates metabolomics insights with Elucidata’s Polly PeakML

Tech-Savvy Biologists Company achieves faster, cloud-based CRISPR screening with Elucidata's Polly

a translational research company accelerates immune disorder target discovery with Elucidata

a US-based cancer diagnostics company achieves 100% automation and $1.34M cost savings with Elucidata's Polly

Featured Companies

AddWeb Solution

Artjoker

Building Engines